- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 317/06 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 2 condensed with carbocyclic rings or ring systems
Patent holdings for IPC class C07D 317/06
Total number of patents in this class: 16
10-year publication summary
|
0
|
0
|
3
|
0
|
1
|
1
|
2
|
0
|
0
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Abbott Laboratories | 2257 |
1 |
| Vertex Pharmaceuticals Incorporated | 1586 |
1 |
| Abbott GmbH & Co. KG | 103 |
1 |
| Actavis Group PTC ehf | 395 |
1 |
| Council of Scientific & Industrial Research | 1442 |
1 |
| Daicel Chemical Industries, Ltd. | 185 |
1 |
| Firmenich SA | 1758 |
1 |
| Hyundai Pharm Co., Ltd. | 66 |
1 |
| Italfarmaco SpA | 156 |
1 |
| Eisai R&D Management Co., Ltd. | 1166 |
1 |
| Anadolu Universitesi | 51 |
1 |
| ATAI Life Sciences AG | 35 |
1 |
| Sanofi | 4294 |
1 |
| Baruch Materials (Shenzhen) Co., Ltd. | 2 |
1 |
| Shenzhen Catalys Technology Co., Ltd | 19 |
1 |
| Empathbio, Inc. | 26 |
1 |
| Other owners | 0 |